Avalo Therapeutics, Inc. has grown revenue −85% a year over three years and −61% a year over five. Revenue growth, 3-year annual rate: −85% (Biotechnology median +17%). Revenue growth, 5-year rate: −61%, growth has slowed since the five-year average. Years of annual history on file: 13, FY2013 to FY2025, as filed.

AVTXAvalo Therapeutics, Inc.

Healthcare

$13.43-0.37% 1Y

$13.43

$12.7452 weeks$22.87

Is it growing?

Is AVTX growing?

Avalo Therapeutics, Inc. has grown revenue −85% a year over three years and −61% a year over five.

−85%

Revenue growth, 3-year annual rate · Biotechnology median +17% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −61%
Revenue growth, 5-year rate · −85% over three · growth has slowed since the five-year average
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed

Details›